Aktis Oncology Inc.
AKTS | NASDAQ
$15.27
-$0.66 (-4.14%)
Nov 2, 2026, 9:58 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 37.78M | 37.16M | 29.51M | 128.6M |
Short-Term Investments | 189M | 260.01M | 68.35M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 7.33M | 4.46M | 1.23M | 976K |
Receivables | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a |
Other Current Assets | 3.52M | 3.69M | 2.34M | 3.88M |
Total Current Assets | 230.31M | 300.85M | 100.2M | 132.48M |
Property-Plant & Equipment | 27.25M | 20.87M | 20.92M | 4.87M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 34.58M | 25.33M | 22.15M | 5.84M |
Total Assets | 264.89M | 326.18M | 122.36M | 138.32M |
Account Payables | 1.74M | 1.92M | 957K | 490K |
Deferred Revenue | 18.66M | 9.28M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.56M | 3.08M | 2.03M | 1.19M |
Total Current Liabilities | 31.24M | 18.82M | 6.24M | 5.28M |
Long-Term Debt | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 333.41M | 333.41M | 150.55M | 151.36M |
Total Long-Term Liabilities | 379.8M | 395.16M | 162.42M | 152.28M |
Total Liabilities | 411.03M | 413.98M | 168.66M | 157.55M |
Total Debt | 11.55M | 12.01M | 13.4M | 1.78M |
Book Value | -146.15M | -87.8M | -46.31M | -19.23M |
Book Value Per Share | -2.78 | -2.52 | -1.33 | -0.55 |
Common Stock | n/a | n/a | n/a | n/a |
Retained Earnings | -156.56M | -92.83M | -48.85M | -20.21M |
Comprehensive Income | 42K | 124K | 82K | n/a |
Shareholders Equity | -146.15M | -87.8M | -46.31M | -19.23M |
Total Investments | 189M | 260.01M | 68.35M | n/a |
Add to Watchlist
Select watchlists to add or remove AKTS